## Synthesis
- 
## Source [^1]
- a group of oral hypoglycaemic drugs used in the treatment of type 2 diabetes mellitus. Through inhibiting the enzyme dipeptidyl peptidase-IV they enhance the action of glucagon-like peptide1. Five drugs in this group are currently licensed for use in the UK: sitagliptin, vildagliptin, saxagliptin, linagliptin, and alogliptin.
## References

[^1]: [[Home Page - Concise Medical Dictionary 10th Edition by Oxford Reference]]